Home / Formulary / CJC-1295 (no DAC)

Back to formulary

CJC-1295 (no DAC) — LORIUM lyophilised vial

LORIUM · 10 mg LYOPHILISED VIAL

Third-party tested · COA included with every lot

Growth ● In stockPrescription required

CJC-1295 (no DAC)

Name: CJC-1295 (no DAC)
Brand: LORIUM
SKU: cjc-1295
Availability: InStock

GHRH analogue · CJC-1295

CJC-1295 (No DAC) is a premium GHRH analogue engineered to selectively stimulate the anterior pituitary gland. By delivering a targeted upregulation of growth hormone and IGF-1, this protocol amplifies natural cellular repair and metabolic efficiency while fully preserving the body's natural pulsatile patterns.

$139 / month · 10 mg

Request through a provider Start intake to prescribe

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. It is dispensed only pursuant to a valid prescription following evaluation by a licensed provider.

Researched effects

Effects observed in the cited literature. Individual results are not guaranteed. Statements have not been evaluated by the FDA.

Sustained GH Elevation

Supports a robust 2 to 10-fold increase in growth hormone for 6–8 hours.

Parallel IGF-1 Optimization

Drives a reliable 1.5 to 3-fold increase to trigger cellular repair.

Lean Muscle Development

Enhances protein synthesis and nitrogen retention via IGF-1 pathways.

Accelerated Tissue Recovery

Stimulates collagen synthesis, tissue remodeling, and physical repair.

Pulsatile Precision

Amplifies natural GH release without disrupting biological cycles.

Targeted Fat Metabolism

Enhances baseline lipolysis, fat oxidation, and metabolic profiles.

Deep Sleep Optimization

Promotes high-quality, restorative slow-wave and REM sleep cycles.

Specifications

ClassGHRH analogue

CAS number863288-34-0

Molar mass3367.97 g/mol

Available sizes10 mg

AdministrationPremium subcutaneous optimization protocol.

CategoryGrowth

View a sample certificate of analysis →

Clinical references

Teichman, S. L., et al. (2006). GH and IGF-1 Secretion by GHRH Analogue. J Clin Endocrinol Metab, 91(3).
Ionescu, M., & Frohman, L. A. (2006). Pulsatile GH Secretion Under GHRH Stimulation. J Clin Endocrinol Metab, 91(12).
Sackmann-Sala, L., et al. (2009). GH/IGF-1 Axis and Serum-Protein Profiles. Growth Horm IGF Res, 19(6).
Alba, M., et al. (2006). GHRH Analogue Administration and Hormonal Axes. Am J Physiol Endocrinol Metab, 291(6).